Research programme: serotonin 2A receptor agonists - Alcon

Drug Profile

Research programme: serotonin 2A receptor agonists - Alcon

Alternative Names: AL-34659; Serotonin 2A receptor agonists research programme - Alcon

Latest Information Update: 12 Apr 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Alcon
  • Class
  • Mechanism of Action Serotonin 2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Glaucoma

Most Recent Events

  • 06 Apr 2006 This programme is still in active development
  • 04 Sep 2005 Preclinical trials in Glaucoma in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top